methoxyhydroxyphenylglycol has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajic, KT; Bitar, MS; Farook, T; Pilcher, CW; Thomas, MI | 1 |
| Christensen, NJ; Dejgaard, A; Hilsted, J | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Diabetic Neuropathies
| Article | Year |
|---|---|
Spinal cord noradrenergic dynamics in diabetic and hypercortisolaemic states.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Hormone Antagonists; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Mifepristone; Norepinephrine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord | 1999 |
Plasma dihydroxyphenylglycol (DHPG) as an index of diabetic autonomic neuropathy.
Topics: Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 1988 |